Available Items
NVCA Submits Amicus Brief on Prometheus vs. Mayo Clinic Case NVCA/MedIC Comments on CDHR New Benefit Risk Framework Guidance (Worksheet) NVCA/MedIC Comments on CDHR Recommendations to Clinical Trial Designs
NVCA/MedIC Comment on IOM Recommendations for 501(k) Process NVCA/MedIC Comment on CDHR Recommendation for Improvement to 510(k) Process
MedIC’s Jonathan Leff Testifies At House Committee on Impact of FDA on Medical Innovation (July 2011)
MedIC Releases Vital Signs (Press Release and Data Slides) NVCA Member Jonathan Leff Testifies on Improving FDA Approval Process NVCA Board Member Jack Lasersohn Testifies on FDA Reform Priorities NVCA and MEDIC FDA Reform Priorities - April 2011 NVCA Statement Regarding Medical Device Innovation Initiative FDA Impact on Med Tech Innovation Study (Slide Deck, White Paper and NVCA Statement) NVCA & MedIC Comments on Proposed Parallel Review Process of Medical Products
NVCA Member Call: FDA/CMS Parallel Review Initiative for Biologics & Medical Devices, 12-3-10 (mp3) MedIC Frequently Asked Questions MedIC Launch Press Release